Teva Pharmaceutical Industries (TEVA) valuation · P/E 91, rev $17.26B
Teva Pharmaceutical Industries (TEVA) P/E 91, rev $17.26B.
| Metric | Value |
|---|---|
| P/E | 91 |
| Market cap | $45.77B |
| Revenue | $17.26B |
| P/S | 2.7 |
TEVA valuation FAQ
What is TEVA's P/E ratio?
Teva Pharmaceutical Industries (TEVA) trailing P/E is 91 on the latest cached fundamentals snapshot.
What is TEVA's market cap?
Teva Pharmaceutical Industries (TEVA) market cap is $45.77B on the latest cached fundamentals snapshot.
What is TEVA's latest revenue?
Latest cached Teva Pharmaceutical Industries (TEVA) revenue was $17.26B. Statements: https://lician.com/financials/teva
What is TEVA's price-to-sales ratio?
Teva Pharmaceutical Industries (TEVA) price-to-sales (P/S) is 2.7, cached market cap $45.77B divided by revenue $17.26B.
How many TEVA valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Teva Pharmaceutical Industries (TEVA): P/E, Market cap, Revenue, and P/S.
Where is TEVA valuation listed?
Cached valuation multiples for Teva Pharmaceutical Industries (TEVA) are listed at https://lician.com/valuation/teva.
Not investment advice. Figures as filed or reported, not a live feed.